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ARTICLE OPEN
Aerobic exercise and yoga improve neurocognitive function in
women with early psychosis
Jingxia Lin1, Sherry KW Chan1, Edwin HM Lee1, Wing Chung Chang1, Michael Tse2, Wayne Weizhong Su3, Pak Sham1, Christy LM Hui1,
Glen Joe2, Cecilia LW Chan4, PL Khong5, Kwok Fai So6, William G Honer3 and Eric YH Chen1
Impairments of attention and memory are evident in early psychosis, and are associated with functional disability. In a group of
stable, medicated women patients, we aimed to determine whether participating in aerobic exercise or yoga improved cognitive
impairments and clinical symptoms. A total of 140 female patients were recruited, and 124 received the allocated intervention in a
randomized controlled study of 12 weeks of yoga or aerobic exercise compared with a waitlist group. The primary outcomes were
cognitive functions including memory and attention. Secondary outcome measures were the severity of psychotic and depressive
symptoms, and hippocampal volume. Data from 124 patients were included in the ﬁnal analysis based on the intention-to-treat
principle. Both yoga and aerobic exercise groups demonstrated signiﬁcant improvements in working memory (Po0.01) with
moderate to large effect sizes compared with the waitlist control group. The yoga group showed additional beneﬁts in verbal
acquisition (Po0.01) and attention (P= 0.01). Both types of exercise improved overall and depressive symptoms (all P⩽ 0.01) after
12 weeks. Small increases in hippocampal volume were observed in the aerobic exercise group compared with waitlist (P= 0.01).
Both types of exercise improved working memory in early psychosis patients, with yoga having a larger effect on verbal acquisition
and attention than aerobic exercise. The application of yoga and aerobic exercise as adjunctive treatments for early psychosis
merits serious consideration. This study was supported by the Small Research Funding of the University of Hong Kong
(201007176229), and RGC funding (C00240/762412) by the Authority of Research, Hong Kong.
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INTRODUCTION
Cognitive impairments are recognized as a core feature of
schizophrenia. These impairments are detectable in the early
stages of illness, and are relatively stable in comparison with
ﬂuctuating clinical states.1 Both cross-sectional and longitudinal
follow-up studies demonstrated that cognitive impairments are
signiﬁcantly correlated with functional outcomes with medium
effect sizes.2
Cognitive impairments are present in both treated and
untreated patients, and symptomatic stabilization is usually not
accompanied by cognitive improvement.3 The largest and most
rigorous clinical trial failed to ﬁnd any advantages of atypical
antipsychotics for improvement of cognitive functions.4 Besides
medications, non-pharmacological treatments for cognitive
deﬁcits, including social skills training, cognitive remediation
and exercise, are widely explored in schizophrenia. To date,
physical exercise has attracted attention for improving cognitive
functioning and avoiding medication side effects in psychiatric
patients. Apparently robust improvements in clinical symptoms
have been reported as a result of engaging in physical exercise.
Systematic reviews demonstrated that aerobic exercise can reduce
primary symptoms in patients with schizophrenia, and attenuate
secondary symptoms such as depression, self-depreciation and
social withdrawal.5 However, the beneﬁt of physical exercise for
neurocognitive impairment in schizophrenia has not received
comparable attention.6 Recently, a randomized controlled trial
investigated the cognitive impacts of aerobic exercise in chronic
schizophrenic in patients participating in a 12-week cycling
program. A signiﬁcant improvement in short-term memory was
observed, which was associated with an increase in hippocampal
volume.7
Aside from aerobic exercise, other popular forms of exercise
may also have beneﬁcial neurocognitive effects. Yoga is a
body–mind exercise with a distinctive meditative component, and
is particularly popular with women in Asian cultures. The effects of
yoga on symptoms and emotional deﬁcits in schizophrenia have
received increased research attention.8 Signiﬁcant reductions in the
Positive and Negative Syndrome Scale (PANSS) total score, positive,
negative, and general psychopathology subscores were observed in
patients with schizophrenia spectrum disorders treated with yoga
compared with controls.9
The present study aimed to examine a primary hypothesis that
both yoga and aerobic exercise would beneﬁt memory in female
patients with early psychosis, with a superior effect on attention
through yoga. In Hong Kong, yoga is predominantly practiced by
women, and we anticipated recruitment would be most successful
if the study was limited to women. We also wanted to test
whether the ﬁndings of Pajonk et al. (limited to men with chronic
schizophrenia) could be extended to women with early psychosis.
As secondary objectives, we hypothesized that exercise-induced
improvements in cognition might be correlated with clinical
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improvement, and that aerobic exercise would be associated with
an increase in hippocampal volume.
RESULTS
The numbers and ﬂow of patients through the study appears in
Figure 1. One hundred and twenty four patients were included in
the ﬁnal analysis, and 95 completed the 12-week course. The
overall dropout rate was 23.4%, and there were no signiﬁcant
differences in the yoga group (24%), the aerobic exercise group
(27%), and the waitlist control group (18%).
There were no statistically signiﬁcant differences in age, years of
education, length of illness, marital or occupational status,
smoking, substance abuse, or antipsychotic dose between those
participants who completed the study and those who dropped
out. Non-completers had lower scores in verbal acquisition (19.6
vs. 23.6; P= 0.02), and retention (12.0 vs. 15.7; P= 0.01); and had
higher baseline PANSS total scores (55.4 vs. 44.8; Po0.01), largely
related to higher scores on the negative subscale (13.4 vs. 10.4;
P= 0.01) and the general subscale (30.8 vs. 24.8; P= 0.01).
Attendance rates were not signiﬁcantly different in the yoga
group (47%) and aerobic exercise group (58%). Both interventions
were observed by an investigator during each session and were
carried out at the individual-speciﬁc level of activity as described
in the Materials and Methods. No adverse events were reported
during the study.
Primary and secondary outcomes appear in Figure 2, Table 1
and Table 2. When comparing all the three groups with a mixed-
model, Group × Time interactions were statistically signiﬁcant in
verbal acquisition and retention, working memory, and attention,
measured by HKLLT, Digit Span forwards and backwards tests, and
Letter Cancellation test, respectively. When a priori comparisons
were made between the active intervention groups and the
waitlist group, statistically signiﬁcant improvements were
observed in verbal acquisition, working memory and attention
for the yoga group; and in verbal retention and working memory
for the aerobic exercise group. However, the effects of verbal
acquisition (F = 10.81, Po0.01), working memory (F = 9.56,
Po0.01 in Digit Span Forwards test; F = 10.75, Po0.01 in
Backwards test), and attention (F = 7.45, Po0.01) for the yoga
group, and the effect of working memory (F = 6.43, P= 0.014 in
Digit Span Forwards test; F = 30.82, Po0.01 in Backwards test) for
the aerobic exercise remained signiﬁcant when age, education
years, length of illness, and antipsychotic dose were included as
covariates. The effect sizes were moderate-to-large for both yoga
and aerobic exercise.
The effects on cognition observed at 12 weeks in both
intervention groups were maintained at 18 months follow- up.
There were no signiﬁcant changes in verbal acquisition (F = 1.42,
P= 0.24), working memory (F = 0.07, P= 0.80), and attention
(F = 0.65, P= 0.42) in the yoga group; nor in working memory
(F = 0.01, P= 0.92) in the aerobic exercise group at 18 months
compared with 12 weeks.
Overall symptom severity improved both in yoga (F = 11.87,
Po0.01) and aerobic exercise (F = 6.76, P= 0.012) groups, largely
related to improvement in the general subscale (with age, length
of illness and antipsychotic dose as covariates). Negative
symptoms improved in the yoga group (F = 11.70, Po0.01).
Depressive symptoms improved in both yoga (F = 10.38, Po0.01)
and aerobic exercise (F = 8.79, Po0.01) groups after the 12-week
intervention. These effects on clinical symptoms were stable at the
18-month follow-up in both intervention groups. Following the
12-week waitlist period, this group participated in yoga or aerobic
exercise. The improvements at 18 months were similar as those
observed in the 12-week intervention groups.
Both yoga and aerobic exercise signiﬁcantly improved the health-
related quality of life assessed by the SF-36. Both types of exercise
signiﬁcantly improved ‘physical health (F= 6.21, P=0.015 for yoga;
F = 15.52, Po0.01 for aerobic exercise), and ‘psychological
health’ (F= 9.37, Po0.01 for yoga; F = 6.36, P=0.015 for aerobic
exercise).
We did not ﬁnd signiﬁcant changes in either congruent (F = 1.3,
P= 0.28) or incongruent (F = 1.7, P= 0.18) conditions of the Stroop
Color and Word Tests among three groups. There were no
signiﬁcant changes in Figure Rating Scale (F = 0.04, P= 0.96) for
body perception, and Compliance Rating Scale (F = 0.53, P= 0.59)
for medication adherence.
When comparing the changes of hippocampal gray matter
volumes among three groups using the FreeSurfer Linear Mixed
Model, corrected by age and intracranial volume, aerobic exercise
was associated with increased hippocampal gray matter volume
(F = 7.52, P= 0.01), mainly related to increases in the left
hippocampus (F = 5.13, P= 0.03). Yoga did not show signiﬁcant
changes in total hippocampal volume (F = 1.07, P= 0.31).
Figure 1. Flow chart of patients through study. IIT, intention to treat.
Effects of a randomized controlled trial
J Lin et al
2
npj Schizophrenia (2015) 15047 © 2015 Schizophrenia International Research Society/Nature Publishing Group
The change in VO2 max/kg over time in all three groups was
compared. The Group × Time interaction was not statistically
signiﬁcant between the three groups (F = 0.77, P= 0.47), with a
trend of increased VO2 max/kg in aerobic exercise groups (7.7%).
To examine possible associations between cognitive and ﬁtness
changes more closely, we investigated correlations within all
subjects in the study. The correlation between the change in
cognition and ﬁtness parameters failed to reach statistical
signiﬁcance (total: r= 0.07, P= 0.42 for verbal memory, and
r= 0.06, P= 0.51 for working memory). However, there was a
positive correlation between the number of sessions participants
attended and the change in working memory (total: r= 0.26;
P= 0.02).
DISCUSSION
This clinical trial compared the effects of two different types of
exercise on cognition in early psychosis. The most signiﬁcant
ﬁndings were the improvements in working memory, occurring in
both intervention groups. Our ﬁndings are consistent with
the results of Oertel-Knochel et al.,10 who showed improved
performance in working memory and visual learning after a
cognitive training program combined with physical exercise.
Improvement in verbal retention did not reach statistical
signiﬁcance for either type of exercise intervention when covariates
were included. One possible explanation is that retention may be
relatively intact in psychotic patients, as reported by Chan11 and
Paulsen et al.12 As mentioned, a study examining the effects of
aerobic exercise on cognitive performance demonstrated that a
12-week cycling program could improve short-term memory in
men with chronic schizophrenia, accompanied by a signiﬁcant
increase in hippocampal volume.7 However, differences in gender
and the stage of illness between our study and Pajonk et al. may
contribute to the inconsistency.
Currently available evidence for the effects of yoga on cognition
in psychosis patients is limited. Previous studies mainly focused on
the impacts of yoga on symptoms and social functioning. We
observed improved verbal acquisition and Letter Cancellation test
scores after 12-week of yoga training, but not aerobic exercise,
indicating that yoga may yield superior effects on verbal learning
and attention. These results were consistent with a previous study
of patients with major depression, which found yoga practitioners
signiﬁcantly improved attention span compared to participants
treated only with antidepressant medication.13 Findings from
imaging studies seem to lend support to these hypotheses.14
The changes of VO2 max/kg in both intervention groups failed
to be statistically signiﬁcant in the present study. However, there
was a trend towards increased ﬁtness in the aerobic exercise
group. It is not surprising that yoga did not improve VO2 max
because it demands less cardiovascular ﬁtness as a mind-body
exercise. Fitness testing depends on subjective effort as well as
actual ﬁtness. Variable effort could result in apparent reductions in
VO2 max/kg if patients had less motivation at the ﬁtness testing
session. These challenges were also mentioned in a systematic
review and meta-analysis.15 Changes in measures of ﬁtness could
also be complicated by antipsychotic medication treatment.
Antipsychotic drugs with cardiac and peripheral vascular effects
blunt the acute effects of exercise on cardiac stroke volume and
on cardiac output.16 The small sample size (20 in the yoga group,
17 in the aerobic exercise group, and 11 in the control group) with
completed ﬁtness data should also limit the interpretation of the
ﬁtness results.
Colcombe et al. suggested that regular exercise resulted in
greater brain plasticity, adaptability and efﬁciency by increasing
cortical blood ﬂow, modulating synaptic connections, and
developing new neurons.17 A vast amount of evidence in both
animals18 and humans5 demonstrated effects of physical exercise
on the hippocampus, which has an important role in memory. Our
study found a small increase in hippocampal gray matter volume
in the aerobic exercise group, consistent in direction although
more modest in size compared with that reported in chronic male
patients. The mechanisms of improvements in attention by yoga
may be related to particular characteristics of yoga practice.
Yoga emphasizes mental concentration and the control of body
movements, which could contribute to alterations in brain structures
and functions leading to the cognitive enhancements.19
Figure 2. Mean cognitive scores and symptom values for patients in the three groups, according to yhe HKLLT, Digit Span Backwards Test,
Letter Cancellation Test and PANSS total scores at baseline and 12 weeks for verbal acquisition (a), working memory (b), attention (c), and
symptom severity (d).
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Slow-motion body movement is thought to be able to capture the
mind's attention, and body postures in yoga sharpen the sensory
awareness.
Both types of exercise also demonstrated great improvements
on general symptoms. These ﬁndings are consistent with previous
studies of schizophrenia patients.9 The statistically non-signiﬁcant
effects on positive symptoms in the current study could be due to
the relatively mild and stable psychotic symptoms at baseline.
Furthermore, both yoga and aerobic exercise had a statistically
signiﬁcant beneﬁt on depression, which was reported in several
previous clinical studies.20 Possible biological mechanisms
for exercise-induced antidepressive effects include increased
beta endorphins, and changes of endogenous opioid peptide
neurotransmitters.20 Psychological mechanisms, including
improved sleep, increased sense of self-efﬁcacy, increased feelings
of mastery and reduced negative thoughts, were suggested to be
responsible for the effects on depression.21
Dropout analyses showed that non-compliant patients had
larger deﬁcits in cognition and were more severely ill. It
demonstrated that individuals with worse cognitive function or
greater symptoms were less likely to beneﬁt from exercise, which
would be relevant to note as a limitation that the tolerability to
adhere to this kind of intervention may not be comparable across
all individuals. There were no signiﬁcant differences in adherence
rates between yoga (58%) and aerobic exercise (47%). The
attendance rate was not ideal in our study, but comparable or
superior to other community-based studies. The challenges
created by dropouts and sometimes low attendance rates support
Table 1. Measures of cognition, clinical symptoms, quality of life, and hippocampal volume at baseline, after 12 weeks intervention and at 18-month
follow-up
Yoga group Aerobic exercise group Waitlist control group
Baseline 12 weeks 18 months Baseline 12 weeks 18 months Baseline 12 weeks 18 months
Cognition
Sample size 45 38 23 40 31 22 39 33 18
HKLLT-acquisition, mean (s.d.) 23.4 (6.1) 30.1 (6.6) 28.1 (6.3) 22.7 (8.0) 29.1 (8.2) 28.9 (8.2) 22.7 (7.6) 24.7 (8.1) 29.6 (6.7)
HKLLT-retention, mean (s.d.) 15.2 (6.1) 19.8 (6.0) 18.4 (6.5) 15.6 (5.4) 21.3 (7.1) 19.6 (7.5) 14.5 (7.0) 16.5 (7.2) 19.1 (6.9)
Digit span forwards test,
mean (s.d.)
11.7 (2.3) 12.7 (1.8) 12.4 (2.0) 12.1 (1.8) 13.1 (1.2) 12.8 (1.1) 12.3 (1.8) 12.3 (2.1) 13.4 (0.9)
Digit span backwards test,
mean (s.d.)
7.0 (3.0) 8.7 (3.0) 8.5 (3.4) 6.7 (2.5) 9.5 (3.0) 9.4 (3.3) 7.7 (3.3) 7.3 (2.7) 9.2 (3.0)
Letter cancellation test,
Q score, mean (s.d.)
0.76 (0.14) 0.85 (0.18) 0.82 (0.15) 0.72 (0.21) 0.78 (0.19) 0.79 (0.21) 0.75 (0.15) 0.73 (0.17) 0.84 (0.13)
Stroop test congruent
condition, correct items
mean (s.d.)
110.3 (2.6) 111.1 (1.8) 110.9 (1.1) 110.0 (2.7) 110.9 (2.5) 110.6 (1.7) 110.5 (1.6) 110.4 (1.5) 111.4 (1.0)
Stroop test incongruent
condition, corrected items,
mean (s.d.)
105.7 (4.5) 108.2 (3.4) 108.8 (3.3) 105.4 (5.6) 106.9 (4.6) 107.5 (3.6) 103.3 (8.2) 105.5 (6.1) 108.7 (2.8)
Clinical symptoms
Sample size 45 38 23 40 31 22 39 33 18
PANSS total, mean (s.d.) 47.5 (15.4) 37.6 (9.3) 39.1 (9.7) 46.4 (15.9) 39.1 (10.9) 35.6 (6.3) 45.9 (15.3) 49.4 (15.8) 42.2 (10.7)
PANSS positive, mean (s.d.) 10.2 (3.7) 8.7 (2.7) 8.6 (2.2) 9.5 (4.5) 8.3 (2.4) 7.8 (1.5) 9.9 (3.8) 10.1 (3.5) 9.9 (4.4)
PANSS negative, mean (s.d.) 10.8 (4.2) 8.5 (2.7) 8.4 (3.1) 10.9 (5.6) 9.5 (3.7) 8.1 (2.1) 11.2 (4.1) 12.7 (5.1) 9.6 (3.8)
PANSS general, mean (s.d.) 26.6 (9.3) 20.4 (5.5) 22.1 (7.0) 26.0 (9.2) 21.3 (6.7) 19.6 (3.9) 24.8 (9.2) 26.6 (9.6) 22.7 (5.2)
CDS total, mean (s.d.) 4.1 (4.2) 1.7 (2.4) 2.7 (3.4) 3.3 (4.0) 1.6 (2.3) 1.7 (1.9) 3.7 (4.7) 4.3 (4.3) 1.8 (1.7)
Hippocampal volume (mm3)
Sample size 25 20 28 17 20 13
Left HPC, mean (s.d.) 3,511 (290) 3,459 (259) 3,461 (385) 3,475 (428) 3,533 (314) 3,530 (272)
Right HPC, mean (s.d.) 3,726 (309) 3,667 (262) 3,645 (373) 3,638 (378) 3,726 (326) 3,724 (310)
Total HPC, mean (s.d.) 7,237 (589) 7,126 (506) 7,106 (741) 7,113 (793) 7,259 (629) 7,254 (560)
Quality of Life
Sample size 44 38 40 31 38 32
Physical health, mean (s.d.) 64.1 (16.9) 71.4 (18.0) 64.5 (17.2) 75.0 (17.4) 69.4 (17.4) 68.8 (19.5)
Psychological health,
mean (s.d.)
57.2 (22.0) 67.8 (21.6) 60.0 (19.2) 73.1 (29.6) 60.7 (20.0) 57.2 (23.6)
Body perception
Sample size 44 38 23 40 31 22 38 32 18
FRS, mean (s.d.) 1.8 (1.2) 1.8 (1.4) 2.0 (1.1) 1.5 (1.0) 1.5 (1.2) 1.6 (1.3) 1.6 (1.4) 1.3 (1.3) 1.5 (1.3)
Drug adherence
Sample size 41 37 23 37 31 22 35 32 18
MCR, mean (s.d.) 6.0 (0.7) 6.0 (0.5) 5.9 (0.4) 5.9 (0.8) 6.1 (0.7) 6.0 (0.8) 5.9 (0.5) 6.0 (0.7) 5.9 (0.3)
Fitness
Sample size 38 23 35 18 23 11
VO2 max 25.3 (6.2) 25.9 (5.5) 27.1 (5.4) 29.2 (5.9) 26.1 (5.0) 26.0 (5.2)
Abbreviations: CDS, calgary depression scale; FRS, ﬁgure rating scale; HKLLT, Hong Kong list learning test; HPC, hippocampus; MCR, medication compliance
rating; PANSS, positive and negative syndrome scale.
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the suggestion by Vancampfort et al. that motivational techniques
need consideration to improve exercise adherence in patients
with psychosis.22 The study was limited to women, none had
secondary substance abuse and very few were smokers. Further
study in a more heterogenous cohort is needed to clarify
the extent to which the ﬁndings may be generalizable. Finally,
although every effort was made to avoid unblinding, it is
always possible that blinding may have been compromised in
some cases.
The potentially confounding variables including antipsychotic
dose were controlled for statistically in the analyses, and no
complicating effects were apparent. Arguably, patients in the
waitlist group may not serve as an adequate control because
of less social contact compared with the patients of the
intervention groups. Regular psychoeducation sessions for
the waitlist group in future studies could help control for
this possibility. Follow-up study is needed to examine whether
these beneﬁts by exercise can be maintained in a long-term
period. With the beneﬁts in cognition and symptoms, and the
advantages of being low-cost and have few if any side-effects,
both aerobic exercise and yoga could have potential clinical
signiﬁcance and value as adjunctive therapies for patients with
psychosis.
MATERIALS AND METHODS
Participants and randomization
This was a single blind, randomized, control study conducted in Hong
Kong from Oct 2010 to May 2014. All participants were recruited from the
Early Assessment Service for Young People with Psychosis (EASY) program
in Hong Kong. Only female patients diagnosed with schizophrenia,
schizoaffective disorder, schizophreniform disorder, brief psychotic
Table 2. Statistical signiﬁcance and associated effect sizes of comparisons within and between the groups over 12 weeksa
Yoga and Control Groups Aerobic exercise and Control Groups
Time Group× Time ES (Cohen’d) Time Group × Time ES (Cohen’d)
F P value F P value F P value F P value
Verbal acquisition 37.24 o0.010 10.81 o0.010 0.97 21.19 o0.010 5.72 0.020 0.83
Verbal retention 37.81 o0.010 5.22 .026 0.40 29.41 o0.010 6.20 0.016 0.56
DS forwards test 5.71 0.020 9.56 o0.010 0.77 2.65 0.109 6.43 0.014 0.59
DS backwards test 2.79 0.100 10.75 o0.010 0.71 13.60 o0.010 30.82 o0.010 1.08
LC Q score 3.86 0.054 7.45 o0.010 0.69 1.08 0.303 3.13 0.082 0.22
Stroop test congruent condition, correct items 1.81 0.183 2.00 0.162 0.34 0.90 0.347 0.89 0.349 0.30
Stroop test incongruent condition, correct items 8.50 o0.010 0.28 0.597 0.12 4.61 0.035 1.13 0.292 0.36
PANSS total 1.02 0.316 11.87 o0.010 1.54 0.11 0.747 6.76 0.012 1.14
PANSS positive 0.87 0.354 2.80 0.099 0.51 0.88 0.351 3.37 0.071 0.29
PANSS negative 0.04 0.838 11.70 o0.010 0.91 0.75 0.392 3.50 0.067 0.61
PANSS general 1.36 0.249 11.09 o0.010 0.95 0.35 0.556 6.63 0.013 0.32
CDS total 0.58 0.451 10.38 o0.010 0.74 0.38 0.538 8.79 o0.010 0.58
QoL (physical health) 0.91 0.343 6.21 0.015 0.46 4.35 0.042 15.52 o0.010 0.62
QoL (psychological health) 0.95 0.333 9.37 o0.010 0.65 1.29 0.261 6.36 0.015 0.73
Body perception (FRS) 1.69 0.198 1.14 0.288 0.37 2.43 0.124 0.32 0.577 0.23
Drug adherence (CRS) 0.08 0.786 0.41 0.525 0.21 1.30 0.259 0.06 0.816 0.13
VO2 max 0.25 0.624 0.12 0.729 0.24 4.08 0.054 0.35 0.560 0.22
Abbreviations: CDS, calgary depression scale; CRS, compliance rating scale; DS, digit span test; ES, effect size; FRS, ﬁgure rating scale; LC, letter cancellation test;
PANSS, positive and negative syndrome scale; QoL, quality of life.
aP values represent the statistical signiﬁcance of the effect of time and of the Group× Time interaction in a mixed model in unstructured variance matrix. Age,
education years, length of illness, and antipsychotic dose were included as covariates for cognitive data analysis, and age, length of illness and antipsychotic
dose were included as covariates for clinical data analysis.
Table 3. Assessments used at baseline and 12 weeks
Measures
Physical ﬁtness VO2 max test Maximum capacity of an individual’s body to transport and utilize oxygen
during incremental exercise.
Cognitive function Hong Kong list learning test (HKLLT) Verbal memory
Digit span test Working memory
Letter cancellation test Attention
Stroop color and word tests Executive function
Clinical symptoms Positive and negative syndrome scale
(PANSS)
Clinical symptoms
Calgary depression scale (CDS) Depressive symptoms for schizophrenia
Brain structures Structural magnetic resonance imaging
(MRI)
—
Body perception Figure rating scale (FRS) —
Medication adherence Compliance rating scale (CRS) —
Quality of life The short form (36) health survey (SF-36) —
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disorders, psychosis not otherwise speciﬁed and delusional disorder
(according to the DSM-IV) within 5 years of onset were approached to
participate. Those with severe physical illness or other contraindications to
exercise according to the American College of Sports Medicine guidelines
were excluded. Participants ranged from 16 to 60 years of age (mean (s.d.):
24.6 (7.6) years), with no difference in mean age between groups (Table 3).
Sample size was estimated from previous studies, where memory
improvement was demonstrated after aerobic exercise intervention,
incorporating a two-sided 5% signiﬁcance level and a power of 80%
together with an anticipated dropout rate of 30%. A randomization list was
created using a random number generator. The random list had a block
size of 12 (i.e., for every 12 participants, 4 would be assigned to the yoga
group, 4 to the aerobic exercise group and 4 to the control group). This
sequence of randomization was continued for all 140 subjects. The
randomization list was concealed from research staff involved in
assessment. All patients attended an outpatient clinic and were provided
with protocol-based case management intervention. There were no
statistically signiﬁcant differences in years of education, length of illness,
PANSS and CDS total scores at the baseline amongst the three groups.
Antipsychotic medications were administered as monotherapy (n=109) or
polypharmacy (n= 8). The frequently used antipsychotics were risperidone
(26.5%), olanzapine (20.5%), quetiapine (17.1%), aripiprazole (13.7%),
amisulpride (7.7%), and clozapine (5.1%). Five patients did not take any
antipsychotic medication during the study. The protocol was approved by
the Institutional Review Board of the University of Hong Kong. All
participants provided written informed consent.
Study procedure
Patients were randomized into three groups: (i) integrated yoga therapy
group (n= 48), (ii) aerobic exercise group (n= 46), and (iii) waitlist control
group (n=46; Figure 1). Two certiﬁed coaches (with MSc-Exercise Science
or PhD training) conducted aerobic exercise and yoga training, and both
were blinded to the assessment results. Two research assistants carried out
the assessments and were blinded to treatment allocation and the block
size of randomization. The research assistants who performed assessments
were forbidden to discuss information related to group allocation,
participants’ schedule, or activities during the assessment interviews. The
assessment interviews were tape-recorded for conﬁrmation.
Measures
The outcome measures included ﬁtness measures, cognitive performances,
clinical assessment for symptoms, structural imaging, measures of body
perception, medication adherence and quality of life (Table 3). All the
measures have been used in clinical population with good validity and
reliability, and were conducted before and after the study period
(Supplementary Information). All participants were followed up for
18 months and were assessed again for cognition and clinical symptoms.
Intervention programs
The intervention programs included integrated yoga therapy and aerobic
exercise (walking and cycling). Both programs lasted 60min for each
session, and were held three times a week for 12 weeks (Supplementary
Information).
Statistical analysis
Data analysis was based on the Intention-to-Treat (ITT) method that
included all available data in a mixed-model analysis with a repeated-
measures approach including an unstructured variance matrix (Table 4).
This strategy was based on the assumption that data were missing at
random.23 Differences between the three intervention groups over time
(baseline and 12 weeks) were assessed with a Group× Time interaction
term. Four primary outcome measures (verbal acquisition, verbal retention,
Digit Span backwards test, Letter Cancellation test Q score) were ﬁrst
analyzed by including all three groups (aerobic exercise, yoga, and waitlist)
in analyses, and setting the P value at 0.016. For analyses meeting this
criterion of statistical signiﬁcance, follow-up, a priori comparisons of the
active intervention groups with the waitlist group were carried out with
the same strategy. The P value for statistical signiﬁcance in these analyses
was also set at 0.016. Secondary outcome measures of symptom severity
were carried out comparing each of the two active intervention groups
with the waitlist group, and correction for multiple testing was carried out
with P value at 0.016. Age, years of education, length of illness, and
antipsychotic dose (CPZ equivalents) were included as covariates for
cognitive data analysis; age, length of illness, and antipsychotic dose were
included as covariates for clinical data analysis. Bivariate correlations were
used to analyze whether the changes in cognition were associated with
the number of sessions attended, or with the amount of change of aerobic
ﬁtness.
For statistical analysis of imaging data, following segmentation that
included use of a multi-atlas technique (Supplementary Information)
hippocampal volume data were analyzed with linear mixed effects
Models16 in the Freesurfer package. This approach to modeling includes
all participants with a baseline scan (whether or not an outcome scan was
Table 4. Demographic information for subjects participating in the
study
Mean (s.d.)
Yoga group
(n= 45)
Aerobic
exercise group
(n= 40)
Waitlist
control group
(n= 39)
Demographic characteristics
Age, y 23.8 (6.8) 24.6 (7.9) 25.3 (8.1)
Education, y 12.0 (2.1) 13.1 (3.3) 12.2 (2.6)
Length of illness, y 2.5 (2.1) 2.4 (2.0) 2.0 (2.0)
Smoking, no. (%)
Never smoker 42 (93.3) 35 (87.5) 38 (97.4)
Past smoker 0 1 (2.5) 0
Current smoker 3 (6.7) 4 (10.0) 1 (2.6)
Substance abuse, no. (%)
No substance abuse 45 (100) 40 (100) 39 (100)
Substance abuse 0 0 0
Diagnosis, no. (%)
Schizophrenia 21 (47.7) 20 (50.0) 19 (50.0)
Schizoaffective
disorder
4 (9.1) 6 (15.0) 3 (7.9)
Schizophreniform
disorder
0 1 (2.5) 0
Brief psychosis 2 (4.5) 3 (7.5) 0
Psychosis NOS 16 (36.4) 8 (20.0) 15 (39.5)
Delusional disorder 1 (2.2) 2 (5.0) 1 (2.6)
Antipsychotic
medication dose, CPZ
339 (263) 288 (240) 260 (211)
Antipsychotic
medication, no. (%)
First generation antipsychotics
Haloperidol 0 0 1 (2.9)
Flupenthixol 0 0 1 (2.9)
Zuclopenthixol 2 (4.4) 1 (2.6) 0
Perphenazine 0 0 1 (2.9)
Triﬂuoperazine 2 (4.4) 0 0
Second generation antipsychotics
Clozapine 3 (7.0) 3 (7.7) 0
Risperidone 8 (18.6) 11 (28.2) 12 (34.3)
Olanzapine 11 (25.6) 7 (17.9) 6 (17.1)
Quetiapine 9 (20.9) 4 (10.3) 7 (20.0)
Amisulpiride 4 (8.9) 3 (7.7) 2 (5.7)
Ziprasidone 0 1 (2.6) 0
Aripiprazole 3 (7.0) 8 (20.5) 5 (14.3)
Sulpiride 0 1 (2.6) 0
Clinical symptoms
PANSS score
Total 47.51 (15.4) 46.35 (15.9) 45.87 (15.3)
Positive 10.2 (3.7) 9.5 (4.5) 9.9 (3.8)
Negative 10.8 (4.2) 10.9 (5.6) 11.2 (4.1)
General 26.6 (9.3) 26.0 (9.2) 24.8 (9.2)
CDS total score 4.1 (4.2) 3.3 (4.0) 3.7 (4.7)
Abbreviations: CPZ, chlorpromazine; CDS, calgary depression scale; PANSS,
positive and negative syndrome scale; y, years.
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obtained), and takes into account time between baseline and outcome
scan, age and intracranial volume.
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